Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Novartis Now Expects 2024 Net Sales To Grow High Single To Low Double-Digit And Core Operating Income To Grow Mid- To High Teens (Prior Low Double-Digit To Mid-Teens)

Author: Benzinga Newsdesk | July 18, 2024 01:23am

Posted In: NVS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist